Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
2388 | 2193 | 40.8 | 58% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | PERSISTENT VIRAL DIS | Address | 12 | 18% | 3% | 59 |
2 | FRIEND VIRUS | Author keyword | 12 | 50% | 1% | 17 |
3 | MOMULV TS1 | Author keyword | 11 | 100% | 0% | 6 |
4 | FRIEND MURINE LEUKEMIA VIRUS | Author keyword | 6 | 80% | 0% | 4 |
5 | SL3 3 | Author keyword | 6 | 100% | 0% | 4 |
6 | MURINE LEUKEMIA VIRUS | Author keyword | 5 | 18% | 1% | 25 |
7 | FV 4 | Author keyword | 4 | 75% | 0% | 3 |
8 | MOLONEY | Author keyword | 4 | 75% | 0% | 3 |
9 | ECOTROPIC | Author keyword | 4 | 46% | 0% | 6 |
10 | FRIEND SPLEEN FOCUS FORMING VIRUS | Author keyword | 3 | 100% | 0% | 3 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | FRIEND VIRUS | 12 | 50% | 1% | 17 | Search FRIEND+VIRUS | Search FRIEND+VIRUS |
2 | MOMULV TS1 | 11 | 100% | 0% | 6 | Search MOMULV+TS1 | Search MOMULV+TS1 |
3 | FRIEND MURINE LEUKEMIA VIRUS | 6 | 80% | 0% | 4 | Search FRIEND+MURINE+LEUKEMIA+VIRUS | Search FRIEND+MURINE+LEUKEMIA+VIRUS |
4 | SL3 3 | 6 | 100% | 0% | 4 | Search SL3+3 | Search SL3+3 |
5 | MURINE LEUKEMIA VIRUS | 5 | 18% | 1% | 25 | Search MURINE+LEUKEMIA+VIRUS | Search MURINE+LEUKEMIA+VIRUS |
6 | FV 4 | 4 | 75% | 0% | 3 | Search FV+4 | Search FV+4 |
7 | MOLONEY | 4 | 75% | 0% | 3 | Search MOLONEY | Search MOLONEY |
8 | ECOTROPIC | 4 | 46% | 0% | 6 | Search ECOTROPIC | Search ECOTROPIC |
9 | FRIEND SPLEEN FOCUS FORMING VIRUS | 3 | 100% | 0% | 3 | Search FRIEND+SPLEEN+FOCUS+FORMING+VIRUS | Search FRIEND+SPLEEN+FOCUS+FORMING+VIRUS |
10 | NEUROPATHOGENICITY | 3 | 35% | 0% | 6 | Search NEUROPATHOGENICITY | Search NEUROPATHOGENICITY |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DISEASE SPECIFICITY | 53 | 69% | 2% | 46 |
2 | TS1 | 53 | 89% | 1% | 24 |
3 | NEUROTROPIC RETROVIRUS | 48 | 100% | 1% | 17 |
4 | C RNA VIRUS | 47 | 86% | 1% | 24 |
5 | LEUKEMIA VIRUS TB | 44 | 100% | 1% | 16 |
6 | PARALYTOGENIC MUTANT | 44 | 88% | 1% | 21 |
7 | NONDEFECTIVE FRIEND | 40 | 82% | 1% | 23 |
8 | FOCUS FORMING VIRUSES | 40 | 76% | 1% | 28 |
9 | HOST GENETIC CONTROL | 34 | 93% | 1% | 13 |
10 | INDUCED SPONGIFORM NEURODEGENERATION | 32 | 88% | 1% | 15 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The mouse "xenotropic" gammaretroviruses and their XPR1 receptor | 2010 | 24 | 158 | 47% |
FRIEND VIRUS-INDUCED ERYTHROLEUKEMIA AND THE MULTISTAGE NATURE OF CANCER | 1991 | 225 | 20 | 45% |
MOLECULAR-BIOLOGY OF FRIEND VIRAL ERYTHROLEUKEMIA | 1989 | 139 | 173 | 60% |
The role of CD4 and CD8 T cells in recovery and protection from retroviral infection: Lessons from the friend virus model | 2000 | 33 | 33 | 61% |
Retroviral insertional mutagenesis as a strategy to identify cancer genes | 1996 | 134 | 380 | 25% |
Friend erythroleukemia revisited | 2000 | 43 | 86 | 41% |
Friend Spleen Focus-Forming Virus Activates the Tyrosine Kinase sf-Stk and the Transcription Factor PU.1 to Cause a Multi-Stage Erythroleukemia in Mice | 2010 | 5 | 76 | 62% |
Deregulation of erythropoiesis by the Friend spleen focus-forming virus | 1999 | 37 | 133 | 48% |
HOST GENETIC-CONTROL OF SPONTANEOUS AND INDUCED IMMUNITY TO FRIEND MURINE RETROVIRUS INFECTION | 1990 | 77 | 25 | 80% |
Dissecting the determinants of neuropathogenesis of the murine oncornaviruses | 1998 | 14 | 100 | 64% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | PERSISTENT VIRAL DIS | 12 | 18% | 2.7% | 59 |
2 | VIROL PROD | 2 | 50% | 0.1% | 3 |
3 | GENE TECHNOL SAFETY | 1 | 33% | 0.1% | 2 |
4 | PATHOL IMMUNOL AGING DEV SCI | 1 | 18% | 0.2% | 4 |
5 | ABT MED MIKROBIOL VIROL | 1 | 50% | 0.0% | 1 |
6 | AUTOIMMUNE INFLAMMAT DIS | 1 | 50% | 0.0% | 1 |
7 | BONE BIOL SECT | 1 | 50% | 0.0% | 1 |
8 | COMM STUDY MOLEC GENET | 1 | 50% | 0.0% | 1 |
9 | DISPLITA VIALBA | 1 | 50% | 0.0% | 1 |
10 | EXPTL PATHOL CHIKUSA KU | 1 | 50% | 0.0% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000195949 | GENE THER Y S//PATHOTROPIC TARGETING//RETROVIRAL ENTRY |
2 | 0.0000116162 | MAIDS//LP BM5//LP BM5 MURINE LEUKEMIA VIRUS |
3 | 0.0000104878 | XMRV//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS XMRV |
4 | 0.0000100083 | VL30//INTRACISTERNAL A PARTICLE//EARLY TRANSPOSON |
5 | 0.0000082607 | AVIAN LEUKOSIS VIRUS//AVIAN LEUKOSIS VIRUS SUBGROUP J//MYELOID LEUKOSIS |
6 | 0.0000075769 | ANTI B CELL ANTIBODY//FOLLICULAR CENTER CELL//IN SITU IMMUNOPHENOTYPING |
7 | 0.0000059582 | IKAROS//AIOLOS//BCL11B |
8 | 0.0000058827 | MU MSV//CLA PTX//EPIDERMIS PROLIFERATION |
9 | 0.0000057047 | ANIM GENET BIOINFORMAT//BASIC PROGRAMMAMMALIAN GENET//FREDERICK CANC ILBIONET INC |
10 | 0.0000052472 | MOUSE MAMMARY TUMOR VIRUS//VIRAL SUPERANTIGEN//MAMMARY TUMOR VIRUS |